Application 216993

Type
NDA
Sponsor
DAIICHI SANKYO INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001VANFLYTAQUIZARTINIB DIHYDROCHLORIDETABLET;ORALEQ 17.7MG BASEYesNo
002VANFLYTAQUIZARTINIB DIHYDROCHLORIDETABLET;ORALEQ 26.5MG BASEYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85791SUPPL 2026-05-01
85687SUPPL 2026-04-15
85684SUPPL 2026-04-15
78925SUPPL 2024-06-27
78900SUPPL 2024-06-26
76272ORIG 2023-11-03
75066ORIG 2023-08-14
74845ORIG 2023-07-21
74820ORIG 2023-07-20
74819ORIG 2023-07-20